Subscribe
Business

PTC Therapeutics rises after company completes IPO

By Washington Examiner
Published
Add Washington Examiner on Google

NEW YORK (AP) — Shares of PTC Therapeutics Inc. are climbing in morning trading after the drug developer completed its initial public offering.

PTC shares rose $1.55, or 10.3 percent, to $16.55 in midday trading, after earlier spiking to $16.90.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.